| CPC A61K 41/0057 (2013.01) [A61F 9/0017 (2013.01); A61F 9/0079 (2013.01); A61K 9/0048 (2013.01); A61K 31/525 (2013.01); A61K 33/00 (2013.01); A61K 33/26 (2013.01); A61N 5/062 (2013.01); A61P 27/02 (2018.01); A61P 43/00 (2018.01); A61N 2005/0661 (2013.01)] | 14 Claims |

|
1. A method for treating corneal damage associated with a pathogen infection in an eye, comprising:
identifying an eye infected by a pathogen;
applying an eye drop formulation to an area of the eye infected by the pathogen, the formulation including:
a photosensitizer;
one or more non-ionic permeability enhancers; and
at least one additive selected from the group consisting of iron, copper, manganese, chromium, vanadium, aluminum, cobalt, mercury, cadmium, nickel, arsenic, 2,3-butanedione, and folic acid; and
delivering a dose of illumination having a fluence rate ranging from about 15 mW/cm2 to about 45 mW/cm2 in combination with pulsed oxygen to the area of the eye thereby photoactivating the photosensitizer and cross-linking corneal tissue at a depth that does not damage endothelium.
|